Applicant, as named in the Orange Book

Kai Pharms Inc

Next listed expiry: Parsabiv on 27 Jun 2034. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Parsabiv · 3 strengths etelcalcetide	etelcalcetide	208325	27 Jun 2034	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.